Skip to main content
. 2022 Mar 3;39(4):995–1008. doi: 10.1007/s10815-022-02432-0

Table 2.

Demographic and hormonal features of two groups of PCOS patients

Characteristic Treatment group (n = 20) Control group (n = 20) P value
Age (y) 30.60 ± 4.98 30.45 ± 3.98 0.917
BMI (kg/m2) 28.91 ± 4.52 27.72 ± 5.47 0.458
E2 (pg/mL) 85.79 ± 46.76 80.12 ± 38.45 0.678
P (ng/mL) 1.26 ± 0.86 1.27 ± 0.87 0.978
PRL (ng/mL) 11.72 ± 6.31 12.14 ± 5.78 0.828
LH (mU/mL) 16.01 ± 7.47 14.06 ± 7.91 0.430
FSH (mU/mL) 4.79 ± 1.97 4.69 ± 1.44 0.857
AMH 12.28 ± 6.30 12.78 ± 6.29 0.800
TSH 2.18 ± 1.04 2.04 ± 0.98 0.658

Values are presented as mean ± SD. Treatment group received AST; control group received placebo. No statistically significant differences were found between the treatment group and the control group. BMI body mass index, E2 estradiol, P progesterone, PRL prolactin, LH luteinizing hormone, FSH follicle-stimulating hormone, AMH anti-Müllerian hormone, TSH thyroid-stimulating hormone